Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

CMF regimen

View Patient Information
A regimen consisting of cyclophosphamide, methotrexate and fluorouracil, used as a neoadjuvant or adjuvant treatment for breast cancer; also used for the treatment of recurrent and metastatic breast cancer.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:cyclophosphamide-methotrexate-fluorouracil regimen
cytoxan-methotrexate-fluorouracil regimen
oral cyclophosphamide/methotrexate/fluorouracil
Abbreviation:CMF
CTX/5-FU/MTX
Code name:cyclophosphamide/fluorouracil/methotrexate
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search